WEAVE COMMUNICATIONS INC (WEAV)
Information Technology · Healthcare practice management software / patient engagement SaaS · NYSE
An AI-powered unified communication and workflow platform that serves as the operational backbone for small and medium-sized healthcare practices, automating patient interactions and administrative tasks to improve practice efficiency and patient engagement.
What WEAVE COMMUNICATIONS INC does
Weave is a vertical SaaS platform delivering AI-powered patient engagement and communication solutions purpose-built for small and medium-sized healthcare practices. The platform unifies voice, text, appointment scheduling, staff collaboration, payment processing, and AI-powered workflows into a single system that manages the complete patient lifecycle from pre-care through post-care operations. By automating administrative workflows and leveraging agentic AI as an "always-on teammate," Weave reduces front-office burdens and allows clinical staff to focus on face-to-face patient care.
Themes: AI-powered patient engagement, Healthcare practice management software, SMB healthcare technology, Unified communications platform, Healthcare payment processing, Practice automation and workflow optimization, Agentic AI for administrative tasks, Dental and optometry software, Specialty medical practice tools
Fundamentals
- Price$7.29 as of 2026-08-21 close
- Market cap$583M as of 2026-08-21
- 1-year return-4.5% 2025-08-21 close $7.63 → 2026-08-21 close $7.29
- P/En/a negative earnings
- Net margin-10.1% as of 2026-08-24
- Gross margin+72.3% as of 2026-08-24
- ROE-30.9% as of 2026-08-24
- Debt / equity0.16 as of 2026-08-24
- Revenue growth (YoY)+16.8% as of 2026-08-24
- Revenue CAGR (3y)+18.9% SEC XBRL
- Beta1.70 as of 2026-08-24
- Last reported earnings2026-08-06 SEC EDGAR Form 8-K (Item 2.02)
How WEAV compares in its sector
- net profit marginbottom 25% 405 covered Information Technology peers, as of 2026-08-24
- operating marginbottom 25% 405 covered Information Technology peers, as of 2026-08-24
- gross marginmiddle range 403 covered Information Technology peers, as of 2026-08-24
- return on equitybottom 25% 405 covered Information Technology peers, as of 2026-08-24
- 3-year revenue CAGRtop 25% 386 covered Information Technology peers
- free cash flow (absolute dollars, latest fiscal year)middle range 382 covered Information Technology peers, as of FY2025
Position among covered Information Technology companies that report each metric (minimum 5 peers). A relative position within our covered catalog — not a valuation, quality, or investment judgment. A higher percentile is simply a higher value (for P/E, more expensive on earnings — never "better"). Informational only.
How WEAVE COMMUNICATIONS INC looks technically
WEAVE COMMUNICATIONS INC (WEAV) is trading 21.3% above its 200-day average, the long-term trend line — a longer-term uptrend. Its 50-day average crossed above its 200-day average about 19 trading days ago — a "golden cross", a bullish long-term signal. A trend is forming but not yet strong — ADX, a 0–100 trend-strength gauge, is 22 (a reading of 25+ marks a strong trend). Momentum is neutral — its 14-day RSI (a 0–100 momentum gauge) is 63, neither overbought (above 70) nor oversold (below 30). MACD, a trend-momentum gauge, turned bullish about 4 trading days ago (its momentum flipped positive). It made a new 20-day high about 3 trading days ago.
Trend
9
| Distance from the 200-day | it is trading 21.3% above its 200-day average, the long-term trend line — a longer-term uptrend | +21.3% |
|---|---|---|
| 50-day moving average | its average price over the last 50 trading days — a short-term trend line — is $6.29 | $6.29 |
| 200-day moving average | its average price over the last 200 trading days — the long-term trend line — is $6.01 | $6.01 |
| Swing structure | each recent peak has been lower than the one before it and each dip deeper — the pattern chart-watchers call a downtrend, which describes where price has already been and not where it goes next | lower highs and lower lows |
| Last swing turn | its last significant turn was a swing low 14 calendar days ago — the swings before that are what the structure reading is measured on | 14 sessions |
| Wave structure | its recent swings can be read as a completed three-part downward correction — a pullback in the A-B-C shape Elliott-wave chartists use; the labelling fails if price closes below 4.65. It is the only labelling that fits, and it describes the swings already printed, not what comes next. | possible three-wave downward correction, complete |
| Since the 50/200 cross | its 50-day average crossed above its 200-day average about 19 trading days ago — a "golden cross", a bullish long-term signal | 19 sessions |
| Above the 200-day after a dip | it recently dipped to its 200-day average (the long-term trend line) and has since climbed back above it — now about 21.3% above | +21.3% |
| Trend strength (14-day ADX) | a trend is forming but not yet strong — ADX, a 0–100 trend-strength gauge, is 22 (a reading of 25+ marks a strong trend) | 22.3 |
Momentum
3
| 14-day RSI | momentum is neutral — its 14-day RSI (a 0–100 momentum gauge) is 63, neither overbought (above 70) nor oversold (below 30) | 62.9 |
|---|---|---|
| Position in its 14-day range | it is trading right at the top of its 14-day range ($4.65 to $7.32) — its "stochastic" reading is 99 out of 100, where 0 would mean closing exactly at the 14-session low and 100 exactly at the high. This measures WHERE the price sits inside its recent range, which is a different question from the RSI beside it: RSI is a momentum gauge, measuring how FAST the price has been moving, so a stock can drift quietly to the bottom of its range with an ordinary RSI, or fall sharply and still sit in the middle. It has been slipping within that range over the last few sessions. | 98.9 |
| Since the MACD crossed zero | MACD, a trend-momentum gauge, turned bullish about 4 trading days ago (its momentum flipped positive) | 4 sessions |
Range
12
| 52-week high | its highest closing price over the past year (about 252 trading days) was $8.11 | $8.11 |
|---|---|---|
| From the 52-week high | it is 10.1% below its 52-week high (its highest price of the past year) | -10.1% |
| Above the 52-week low | it is 71.5% above its 52-week low (its lowest price of the past year) | +71.5% |
| Below the 52-week high | it is 10.1% below its highest point of the past year | 10.1% |
| Since a 20-day breakout | it made a new 20-day high about 3 trading days ago | 3 sessions |
| Since a 55-day breakout | it made a new 55-day low about 8 trading days ago | 8 sessions |
| All-time high | its highest closing price on record is $21.48 (set on 2021-11-15) | $21.48 |
| Given back of the 52-week move | over the past year its closes ranged ($4.37 to $8.00), and it has recovered almost all of its fall from last year’s high — 80% of it. Chart-watchers call 61.8%-65% given back the "golden pocket" — for this company that is $6.61 to $6.73. It is watched widely enough that orders cluster there, which is the honest reason it matters; it is not a forecast. | 80.4% |
| From the all-time high | it is 66.1% below its all-time high | -66.1% |
| Nearest price level | it is trading 1.5% below a resistance level at $7.40 — a price it turned at three times since 2025-08-20, most recently on 2025-10-09. Since 2024-08-21 it has 7 such levels below the current price and 12 above. Levels like these describe where the price has reversed or paused before; they are not a forecast of where it will go. | +1.5% |
| All-time low | its lowest closing price on record is $2.91 (set on 2022-07-01) | $2.91 |
| Above the all-time low | it is 150.5% above its all-time low | +150.5% |
Volatility
5
| Band width vs its own 6 months | day-to-day price swings are unusually wide versus its own recent history (wider than about 99% of the past ~6 months) | 99th percentile |
|---|---|---|
| Typical daily range | in a typical session it travels about $0.4124 between its high and its low — about 5.7% of its price. That is its "average true range" over the last 14 sessions, which also counts the distance from the previous close, so a day that opens well away from yesterday counts as the large move it was | $0.4124 |
| Bollinger bands (20-day, ±2σ) | most of its recent trading has stayed between about $4.71 and $7.97 — the "Bollinger bands", a range drawn two standard deviations either side of its 20-day average price, which widens when the stock gets more volatile and narrows when it settles | $4.71 – $6.34 – $7.97 |
| Typical daily range (% of price) | its price moves about 5.7% in a typical session — about typical for the companies we cover. This is the average gap between a session's high and low over the last 14 sessions, counting overnight moves, expressed against the current price so it can be compared with companies trading at any price | 5.7% |
| Stretch from the 200-day average | it is trading 3.1 daily ranges above its 200-day average price (21.3% above it in plain percentage terms) — a way of asking how far it has stretched from its own average in units of how far it normally moves in a day, so a calm company and a jumpy one can be compared on the same scale | 3.1 daily ranges above its 200-day average |
Volume
1
| Volume vs its 30-day average | trading volume is about normal versus its 30-day average | 1.35× |
|---|
Analyst
2
| Change in the average price target | analysts' average price target is unchanged from the prior reading | 0.0% |
|---|---|---|
| Change in the consensus rating | the analyst consensus rating is unchanged since the prior reading | unchanged |
Candlestick patterns
1
| Since a bearish engulfing | 1 session ago it opened above the previous session's close and finished below that session's open — a "bearish engulfing" pair, where one down day more than undid the up day before it | 1 session ago |
|---|
Price gaps
3
| Gap at the open | it opened on 2026-08-21 0.1% above the previous session's close — an overnight gap, the part of the move that happened while the market was shut, and traded back through that level before the close | +0.1% |
|---|---|---|
| Open gap | it gapped 31.8% above the previous close 3 sessions ago and has not traded back through the level it left behind at 5.53 — an "unfilled gap", which describes a price range no trade has since crossed and is not a forecast that it will be crossed | +31.8% |
| Gap filled | a 2.6% gap down opened on 2026-08-12 has been "filled" 7 sessions ago — price traded back through the level the gap left behind, and it closed again during the very session that opened it | 7 sessions ago |
Relative strength
4
| vs market, 1 month | over the past 1 month this stock beat the market by 4.9 percentage points (the stock gained 7.2% while the market gained 2.3%) | +4.9% |
|---|---|---|
| vs market, 3 months | over the past 3 months this stock beat the market by 26.8 percentage points (the stock gained 29.9% while the market gained 3.1%) | +26.9% |
| vs market, 6 months | over the past 6 months this stock beat the market by 23.4 percentage points (the stock gained 34.5% while the market gained 11.1%) | +23.4% |
| vs market, 12 months | over the past 12 months this stock lagged the market by 24.9 percentage points (the stock lost 4.5% while the market gained 20.5%) | -24.9% |
Signal agreement
2
| Bullish technical signals | 6 of the 9 technical signals we can compute for it are currently in a bullish state: a "golden cross" — its 50-day average is above its 200-day, trading above its 200-day average, a fresh 20-day high, MACD momentum is positive, outperforming the market over 6 months, trading above the Ichimoku cloud — these describe past price behaviour, not a forecast | 6 of 9 |
|---|---|---|
| Bearish technical signals | 1 of the 9 technical signals we can compute for it is currently in a bearish state: near the top of its 14-day range (overbought) — these describe past price behaviour, not a forecast | 1 of 9 |
Trend (Ichimoku cloud)
1
| Vs the Ichimoku cloud | trading 9.4% above the Ichimoku cloud — a band drawn from where its own highs and lows sat up to 2026-07-16 and projected forward over today's price, the side traders read as an established uptrend, with the band below acting as the level that would have to give way. The band itself is moderate, spanning 7.2% of the share price. | +9.4% |
|---|
Volume-weighted price
2
| Vs this year’s average price paid | the price is 19% above the average price paid so far this year, so the typical buyer over that stretch is showing a gain. That average is $6.13 — a volume-weighted average of daily closes over 157 sessions, not a true tick-by-tick VWAP. | +19.0% |
|---|---|---|
| Vs the average paid since it last reported | the price is 5% above the average price paid since it last reported on 2026-08-06 (its 10-Q), so the typical buyer over that stretch is showing a gain. That average is $6.95 — a volume-weighted average of daily closes over 12 sessions, not a true tick-by-tick VWAP. | +5.0% |
Price levels it has turned at before
WEAV last closed at $7.29 on 2026-08-21. Since 2024-08-21 it has turned at 7 prices below its last close and 12 above; the 3 nearest below and the 3 nearest above are listed, nearest first.
| Level | Side | Distance | Evidence |
|---|---|---|---|
| $7.40 | Resistance | 1.5% above the last close | turned there three times · 2025-08-20 to 2025-10-09 |
| $7.11 | Support | 2.5% below the last close | turned there twice · 2026-01-26 to 2026-07-29 |
| $7.68 | Resistance | 5.3% above the last close | turned there twice · 2026-01-07 to 2026-07-15 |
| $7.96 | Resistance | 9.2% above the last close | turned there three times · 2025-06-23 to 2025-09-11 |
| $6.44 | Support | 11.7% below the last close | turned there five times · 2025-10-02 to 2026-06-01 |
| $6.25 | Support | 14.3% below the last close | turned there twice · 2025-12-04 to 2026-05-04 |
A level is a price this company reversed or paused at more than once — they describe past behaviour, not a forecast of where the price will go.
Wave structure
Its recent swings can be read as a three-part downward correction — the A-B-C shape chartists use for a pullback — now complete.
This labelling fails — stops being a possible reading at all — if it closes below $4.65.
It is the only labelling that fits these swings, though its proportions are not the textbook ones.
This reading has stood for 4 trading days, since 2026-08-18.
Read from daily closes as of 2026-08-21.
An Elliott-wave count describes the swings already printed and the level that would disprove it. It is not a forecast, a target, or advice.
Screens: Trading above the 200-day moving average · Recent golden cross (50-day crossed above 200-day) · Tested and reclaimed 200-day support · Broke out to a new 20-day high · MACD just crossed bullish (12/26/9) · beating the market | Learn: moving average · golden cross · adx · rsi · macd · breakout
Based on daily closing prices as of 2026-08-21. Describes past price behavior only — informational, not financial advice.
Analyst consensus
- Consensus ratingStrong Buy (1.50 mean, 1=Strong Buy…5=Strong Sell) — 4 analysts
- Mean price target$8.00 range $8.00 – $8.00
Analyst estimates, as of 2026-08-18. These are third-party analyst opinions and price targets, aggregated — not a recommendation, prediction, or advice from stocks-llm. Informational only.
Analyst EPS estimate for WEAV
- Consensus EPS estimate$0.0425 next reporting period, as of 2026-08-18
Change over time is not available yet: it needs two readings of the same reporting period at least 30 days apart, and we have been recording these estimates since 2026-08-04. An estimate for a DIFFERENT quarter is not a revision, so a reading from before the last report is never compared with one after it.
The consensus estimate for the next reporting period, and how it has moved between readings of that SAME period. A change is measured only between readings estimating one period — when a company reports, the consensus moves to the next quarter and the two numbers are not comparable. Informational only, not a forecast and not advice.
Key risks (from latest filing)
["Platform operates in highly fragmented healthcare software market with strong competition from point-solution alternatives; customer acquisition and retention dependent on continued feature development and integration capabilities","High customer acquisition costs with onboarding services and phone hardware generating negative gross profit, creating significant pressure on unit economics and path to profitability","Heavy reliance on healthcare vertical specialization and compliance with strict privacy/regulatory frameworks (HIPAA); any regulatory changes or compliance failures could disrupt operations"]
What changed in the latest 10-Q
AI-assisted comparison of WEAV's 10-Q filed 2026-05-05 against the prior one filed 2025-11-06.
Management's Discussion & Analysis (MD&A)
- Added:
- Newer filing (2026-05-05) adds description of AI as 'always-on teammate' that autonomously fulfills daily tasks like answering routine questions, scheduling appointments, and managing payment processing
- Newer filing (2026-05-05) adds language about 'unifying conversational context across voice and text channels into a single inbox, blending AI agents and staff actions'
- Newer filing (2026-05-05) adds reference to 'nearly two decades of domain expertise and billions of patient interactions' and 'vertically specialized data'
- Newer filing (2026-05-05) adds focus statement: 'We continue to focus on reducing administrative burdens for healthcare practices through agentic AI, embedded automation and real-time operational insights'
- Newer filing (2026-05-05) adds specific reference to 'embedded lease revenue on phone hardware' in revenue description
- Newer filing (2026-05-05) includes financial table data for three months ended March 31, 2026 and 2025 with specific dollar amounts
- Removed:
- Older filing (2025-11-06) describes Weave as 'leading vertical SaaS platform' whereas newer filing (2026-05-05) removes 'leading'
- Older filing (2025-11-06) emphasizes 'From the first phone call to the final invoice and every touchpoint in between' narrative, which is removed in newer filing (2026-05-05)
- Older filing (2025-11-06) includes detailed description of payment/FinTech features ('text-to-pay, online bill pay, and payment plans') and practice profitability benefits that are not present in newer filing (2026-05-05)
- Older filing (2025-11-06) references 'physical and softphones' explicitly, not mentioned in newer filing (2026-05-05)
- Older filing (2025-11-06) uses term 'non-recurring categories' whereas newer filing (2026-05-05) uses 'customer onboarding categories'
- Older filing (2025-11-06) includes 'recurring phone hardware fees' phrasing; newer filing (2026-05-05) uses 'embedded lease revenue on phone hardware'
- Older filing (2025-11-06) includes nine-month period financial data; newer filing (2026-05-05) provides only three-month data
- Older filing (2025-11-06) references 2024 introduction of enhanced Weave platform and Weave Enterprise features; newer filing (2026-05-05) does not include this historical context
- Reworded:
- Older filing (2025-11-06) describes 'patient engagement and payment solutions' whereas newer filing (2026-05-05) states 'patient engagement solutions'
- Older filing (2025-11-06) says solutions 'transform how healthcare practices attract, communicate with, and engage patients'; newer filing (2026-05-05) focuses on 'manage the complete patient lifecycle by automating administrative patient-facing workflows'
- Newer filing (2026-05-05) emphasizes 'owning the full telephony and communication stack' as operational advantage; older filing (2025-11-06) does not highlight this
- Older filing (2025-11-06) states onboarding fees are 'typically non-recurring'; newer filing (2026-05-05) states they 'are primarily associated with'
- Description of phone hardware costs changed from 'recurring phone hardware fees' (older, 2025-11-06) to 'depreciation of phone hardware' (newer, 2026-05-05) with footnote clarification
- Notes:
- Newer filing appears truncated at end of 'Retain and Expand' section; full comparison not possible
- The two filings cover different reporting periods (March 31, 2026/2025 vs. September 30, 2025/2024), which affects data presentation and comparability
- Financial table formats differ slightly but present comparable data for their respective periods
Risk Factors
- Added:
- Added risk factor: 'The use of AI technologies in our platform and our business may not produce the desired benefits, and may result in increased liability, reputational harm, or other adverse consequences.' (filed 2026-05-05)
- Added risk factor: 'Conflicting and evolving regulations regarding AI could result in increased compliance costs, operational constraints, or legal liability.' (filed 2026-05-05)
- Added risk factor: 'Our business could be negatively impacted by actions of stockholders.' (filed 2026-05-05)
- Added revenue figures: '$65.5 million for the three months ended March 31, 2026 compared with $55.8 million for the three months ended March 31 2025' (filed 2026-05-05)
- Added: 'We have also expanded operations to India, Latin America and the Philippines over the last three years.' (filed 2026-05-05)
- Removed:
- Removed risk factor summary item: 'If we do not continue to enhance our platform and products and introduce new products that achieve market acceptance, our business, results of operations and financial condition would be adversely affected.' (older version filed 2025-11-06)
- Removed revenue figures: '$175.6 million for the nine months ended September 30, 2025 compared with $150.1 million for the nine months ended September 30 2024' (older version filed 2025-11-06)
- Removed: 'We have also expanded operations to India and the Philippines over the last three years.' (older version filed 2025-11-06)
- Reworded:
- Changed 'We focus on serving small and medium-sized healthcare practices' to 'We focus on serving small and medium-sized healthcare businesses' (filed 2026-05-05)
- Changed 'If we do not continue to enhance our platform and products and introduce new products' to 'If we do not continue to develop enhancements to our platform and products and introduce new products' in risk factors summary (filed 2026-05-05)
- Changed bullet point order: moved 'manage inflation and interest rate trends' from second position to later position in the dependencies list (filed 2026-05-05)
- Changed 'serve SMBs across a wide cross-section' to 'serve SMB healthcare practices across a wide cross-section' (filed 2026-05-05)
- Notes:
- The older filing text appears truncated at the end ('Our ability to attract new custo'), making full comparison of later sections not assessable
- Revenue figures are from different time periods (Q1 2026 vs. nine months ended Sept 30, 2025), reflecting different reporting periods rather than direct comparable updates
AI-assisted comparison of two SEC filing sections. It describes wording and theme changes only, makes no materiality, legal, or investment judgement, and is not financial advice. Informational only — not financial advice.
Insider activity (SEC Form 4)
No open-market insider purchases or sales are on record for WEAV — recent Form 4 activity was compensation-related (awards, option exercises, or tax withholding), not open-market buying or selling.
View full insider trading history → View SEC Form 3/4/5 filingsOnly open-market purchases (SEC code P) and sales (code S) are counted here. Option exercises, vesting/awards, gifts, and shares withheld for taxes are excluded — they are compensation or mechanical, not open-market conviction. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan) and are not necessarily bearish; open-market buying is not a recommendation to buy. Informational only — not financial advice.
Institutional ownership (13F)
5 institutional 13F filers reported holding WEAV as of 2026-03-31 (quarter-end position, filed within 45 days).
- Distinct 13F filers 5
- Reported shares held 8,601,004
- Reported value $39,736,639
reported quarterly holdings change (2025-12-31 → 2026-03-31): 0 new, 1 increased, 4 decreased, 0 exited. Change counts cover only managers that filed 13F reports in BOTH quarters, derived between two quarter-end snapshots — not same-day trades; a single manager is never said to have "bought" or "sold".
Institutional holdings are quarter-end long positions reported on SEC Form 13F-HR, filed up to 45 days after the quarter ends — they are delayed, are not real-time trades, exclude short positions and most non-US securities, and are not investment advice. Any increase/decrease is a reported change between two quarterly snapshots, not a same-day purchase or sale. These are quarter-end snapshots from the 13F filings on SEC EDGAR, filed within 45 days — not real-time, and any change is a difference between two quarterly reports, not a same-day trade. Informational only — not financial advice.
Short interest (FINRA)
WEAV had 4,935,781 shares of reported short interest as of the 2026-07-31 FINRA settlement date (delayed, bi-monthly; not real-time).
WEAV had 6.17% of its shares outstanding sold short as of the 2026-07-31 FINRA settlement date (percent of FLOAT would be higher — float is not disclosed in the source). FINRA reported 5.13 days to cover at the same settlement.
- Reported short interest (shares) 4,935,781
- Short interest (% of shares outstanding) 6.17%
- Prior settlement (shares) 5,068,300
- Reported change -2.61%
- Days to cover (reported) 5.13
Reported to FINRA as of the 2026-07-31 settlement date. Short interest is reported to FINRA and published on a delayed, bi-monthly schedule (as of a settlement date, disseminated roughly eight business days later) — it is NOT real-time, does not cover every venue or all US trading, and is not a short-squeeze prediction or investment advice. Days-to-cover is the value FINRA reports; percent of float is not shown because the source file carries no share-count denominator — where a percent appears it is of shares OUTSTANDING, the larger base, and is therefore a floor on percent of float. Informational only — not financial advice.
Competitors & peers
- Athenahealth
- Kareo
- Dentrix
- Eaglesoft
- OpenDental
- Henry Schein
- Patterson EHR
AI-enriched competitor set. Linked names are companies covered by stocks-llm; other named peers are shown for reference only.
Compare WEAV vs…
Frequently asked questions
What does WEAVE COMMUNICATIONS INC (WEAV) do?
Weave is a vertical SaaS platform delivering AI-powered patient engagement and communication solutions purpose-built for small and medium-sized healthcare practices. The platform unifies voice, text, appointment scheduling, staff collaboration, payment processing, and AI-powered workflows into a single system that manages the complete patient lifecycle from pre-care through post-care operations.
What sector is WEAVE COMMUNICATIONS INC (WEAV) in?
WEAVE COMMUNICATIONS INC (WEAV) is classified in the Information Technology sector. Its industry is Healthcare practice management software / patient engagement SaaS. It trades on NYSE.
Who are WEAVE COMMUNICATIONS INC's (WEAV) competitors?
Notable peers of WEAVE COMMUNICATIONS INC (WEAV) include Athenahealth, Kareo, Dentrix, Eaglesoft and OpenDental. This peer set is informational only — not financial advice.
Is WEAVE COMMUNICATIONS INC (WEAV) overbought or oversold right now?
WEAVE COMMUNICATIONS INC (WEAV) is currently neither overbought nor oversold — its 14-day RSI (a 0–100 momentum gauge) is 63, in the neutral middle (as of 2026-08-21). RSI describes recent price momentum, not a forecast — informational only, not financial advice.
Where does stocks-llm's data on WEAV come from?
Fundamentals and prices come from market data, as of 2026-08-24; company filings and profile facts come from SEC EDGAR. All figures are delayed daily-close data shown with their as-of date — informational only, not financial advice.
Fundamentals: market data, as of 2026-08-24. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-08-21.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date.